A

AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AstraZeneca PLC
Cost of Revenue Peer Comparison

Comparables:
G
GSK
INDV
HIK
DPH
A
APH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
A
AstraZeneca PLC
NASDAQ:AZN
Cost of Revenue
-$8.7B
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-5%
G
GlaxoSmithKline PLC
NYSE:GSK
Cost of Revenue
-ÂŁ8.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Indivior PLC
LSE:INDV
Cost of Revenue
-$195m
CAGR 3-Years
-18%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Hikma Pharmaceuticals PLC
LSE:HIK
Cost of Revenue
-$1.6B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Dechra Pharmaceuticals PLC
LSE:DPH
Cost of Revenue
-ÂŁ331.9m
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-14%
A
Alliance Pharma PLC
LSE:APH
Cost of Revenue
-ÂŁ74.3m
CAGR 3-Years
-13%
CAGR 5-Years
-9%
CAGR 10-Years
-15%

See Also

What is AstraZeneca PLC's Cost of Revenue?
Cost of Revenue
-8.7B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Cost of Revenue amounts to -8.7B USD.

What is AstraZeneca PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for AstraZeneca PLC have been -8% over the past three years , -14% over the past five years , and -5% over the past ten years .

Back to Top